View Older Stories

Jul 9, 2026 06:16AM Stifel: 'We expect IONS shares to trade lower today and ALNY shares to be volatile'

Jun 30, 2026 06:51AM Canaccord Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)

Jun 29, 2026 07:07AM Alnylam Pharmaceuticals (ALNY) PT Lowered to $470 at H.C. Wainwright

Jun 10, 2026 07:47AM GENESIS Pharma expands Alnylam partnership to Nordic markets

Jun 5, 2026 08:17AM H.C. Wainwright Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)

Jun 3, 2026 04:45PM Alnylam partners with Inceptive in $2B AI collaboration for drug discovery

May 12, 2026 05:27AM Alnylam presents vutrisiran data showing benefits across ATTR-CM patients

May 5, 2026 07:29AM H.C. Wainwright Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)

May 1, 2026 09:52AM Alnylam Pharmaceuticals (ALNY) PT Lowered to $447 at Bernstein SocGen Group

Apr 30, 2026 08:02AM Alnylam Pharma (ALNY) Tops Q1 EPS by 108c, provides guidance

Apr 26, 2026 08:00PM U.S. Biotech stocks: Q1 earnings previews

Apr 24, 2026 08:34AM Alnylam Pharmaceuticals (ALNY) PT Lowered to $448 at Bernstein SocGen

Mar 30, 2026 01:00PM Alnylam presents cardiovascular drug data at medical conference

Mar 26, 2026 06:40AM H.C. Wainwright Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)

Mar 25, 2026 11:39AM Stifel on Alnylam Pharmaceuticals (ALNY): 'positively biased after the pullback'

Mar 24, 2026 03:10PM BofA on Alnylam (ALNY): 'AI-enabled diagnostics will help increase diagnosis rates'

Mar 24, 2026 03:08PM Morgan Stanley: 'we see Amvuttra as well positioned'

Mar 24, 2026 07:30AM Alnylam partners with Viz.ai and American Heart Association on ATTR-CM care

Mar 16, 2026 12:54AM Jefferies Downgrades Alnylam Pharmaceuticals (ALNY) to Hold

Mar 5, 2026 08:31AM Tenaya Therapeutics partners with Alnylam for heart disease targets

Feb 19, 2026 06:48AM H.C. Wainwright Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)

Feb 17, 2026 08:44AM Freedom Capital Markets Upgrades Alnylam Pharmaceuticals (ALNY) to Buy

Feb 13, 2026 09:29AM Alnylam Pharmaceuticals (ALNY) PT Lowered to $450 at RBC Capital

Feb 12, 2026 11:40AM Alnylam Pharmaceuticals (ALNY) PT Lowered to $460 at BofA Securities

Feb 12, 2026 08:04AM Alnylam Pharma (ALNY) Tops Q4 EPS by 6c, Misses on Revenue; Offers FY26 Revenue Guidance

Jan 30, 2026 06:46AM Alnylam Pharmaceuticals (ALNY) PT Raised to $510 at H.C. Wainwright

Jan 20, 2026 05:30AM Alnylam Pharmaceuticals (ALNY) PT Lowered to $465 at RBC Capital

Jan 16, 2026 06:59AM Alnylam Pharmaceuticals (ALNY) Reiterated at Neutral by Cantor Fitzgerald

Jan 13, 2026 06:37AM H.C. Wainwright Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)

Jan 12, 2026 07:20AM Alnylam Pharmaceuticals (ALNY) PT Raised to $529 at Needham

Jan 12, 2026 05:13AM Alnylam Pharmaceuticals (ALNY) PT Lowered to $529 at BofA Securities

Jan 12, 2026 04:48AM Raymond James Reiterates Outperform Rating on Alnylam Pharmaceuticals (ALNY)

Jan 12, 2026 03:59AM RBC Capital on Alnylam Pharmaceuticals (ALNY): '2026 Guide Meaningfully Ahead Of Consensus'

Jan 12, 2026 03:31AM Goldman Sachs Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)

Jan 7, 2026 06:20AM Oppenheimer Assumes Alnylam Pharmaceuticals (ALNY) at Perform

Jan 6, 2026 07:30AM Alnylam Pharmaceuticals (ALNY) PT Lowered at Bernstein Ahead of Next Week's Preannouncement

Dec 21, 2025 04:00AM Biotechnology: Here are Piper Sandler's Top Picks and Focus Names for 2026

Dec 17, 2025 08:02AM Alnylam plans $250 million facility expansion for siRNA manufacturing

Dec 15, 2025 08:44AM Western Digital stock rises after inclusion in Nasdaq-100 Index

Dec 11, 2025 07:34AM Alnylam Pharmaceuticals (ALNY) PT Raised to $508 at Stifel on Vutrisiran Success

Nov 4, 2025 06:51AM H.C. Wainwright Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)

Nov 3, 2025 05:55AM Goldman Shuffles Monthly Director's Cut List for US Names

Oct 31, 2025 05:13AM Alnylam Pharmaceuticals (ALNY) PT Raised to $500 at Oppenheimer

Oct 30, 2025 04:02PM Alnylam Pharmaceuticals (ALNY) PT Raised to $472 at Raymond James

Oct 30, 2025 08:02AM Alnylam Pharma (ALNY) Tops Q3 EPS by $2.38

Oct 27, 2025 07:41AM Bernstein's US Biotech 3Q25 Preview: 'Expect Beats from ALNY and REGN'

Oct 22, 2025 06:45AM Cantor Fitzgerald Reiterates Alnylam Pharmaceuticals (ALNY) at Neutral on Good Execution

Oct 17, 2025 08:32AM Truist Securities: 'Is Biotech Back?!'

Oct 12, 2025 03:00PM Biotech stocks: Q3 earnings preview

Oct 10, 2025 06:40AM H.C. Wainwright Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)

View Older Stories